Stempeutics Receives Japan Process Patent for its Novel Stem Cell Drug … – PR Newswire (press release)
Livemint |
Stempeutics Receives Japan Process Patent for its Novel Stem Cell Drug …
PR Newswire (press release) Commenting on the Japan patent, Mr. B N Manohar, CEO of Stempeutics, said, “The new patent strengthens our position in Japan, which has created an accelerated development path for stem cell therapies. The new regenerative medicine law implemented … Cipla JV Gets Process Patent for Stem Cell Drug From JapanNDTV Stempeutics gets process patent from Japan for stem cell-based drugLivemint Stempeutics receives ODD in EU for its novel stem cell drug “Stempeucel”Zee News Financial Express –Pharmaceutical Processing all 18 news articles » |
ABC Online |
Stem cell therapy dilemma
ABC Online In Australia a loophole in the Therapeutic Goods Administration Act allows the use of ‘autologous’, or a person’s own, stem cells. This treatment isn’t proven to be safe or effective and it’s prompted calls for tougher legislation. But as Hamish … Global Stem Cells Group, Stem Cell Training and Anti-aging Medicine Specialist …Virtual-Strategy Magazine (press release) (registration) (blog) |
|
Accellta Grants Rights for its Feeder-free Stem Cell Culture Medium to Thermo …
PR Newswire (press release) Stem Cell Company Accellta announced today that it has granted worldwide non-exclusive rights to Thermo Fisher Scientific for manufacture and distribution of proprietary cell culture medium and ancillary products and methods. Accellta’s patented … |
Livemint |
Cipla JV Gets Process Patent for Stem Cell Drug From Japan
NDTV New Delhi: Drug major Cipla on Monday said its joint venture firm Stempeutics Research has received a process patent from the Japan Patent Office for novel stem cell drug Stempeucel aimed at treatment of critical limb ischemia (CLI). “The new patent … Stempeutics receives Japan process patent for its stem cell drug ‘Stempeucel’Financial Express Stempeutics gets process patent from Japan for stem cell-based drugLivemint Stempeutics receives Japan process patent for its novel stem cell drug …Hindu Business Line |
|
What do you want to know about adult stem cell research?
OneNewsNow “That debate has kind of gone away a little bit, but most people will remember the debates over embryonic versus adult stem cells, and, of course, the short story is that embryonic — you have to destroy a young human life to get embryonic stem cells … |
Irish Mirror |
Galway stem cell treatment receives €6m in funding
UTV Ireland Orbsen Therapeutics use patented technology to purity stromal (stem) cells, which by 2016 they expect to begin injecting into patients with diabetic kidney disease as part of the first-in-man trials. The trials will take place in Galway, Belfast … Hopes for kidney disease cure with Irish stem cell researchIrish Mirror €6m fund for experimental kidney disease treatmentRTE.ie |
|
Stempeutics receives Japan process patent for its stem cell drug ‘Stempeucel’
Financial Express Stempeutics Research, a group company of Manipal Education and Medical Group and a Joint Venture with Cipla Group, has been granted process patent from the Japan Patent Office (application no 2012-540529) for its novel stem–cell based drug … Stempeutics receives Japan process patent for its novel stem cell drug …Hindu Business Line Stempeutics receives ODD in EU for its novel stem cell drug “Stempeucel”Zee News Stempeutics gets process patent for Stempeucel from JapanBusiness Standard |